Alexandre Cote
37Patents
8h-index
70Co-inventors
78Inventor score
Filing activity: Feb 13, 2001 → Oct 3, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9249161B2 | Bromodomain inhibitors and uses thereof | Chemistry; Metallurgy | 44 | Active |
| US11034694B2 | Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-1-ones as HPK1 antagonists | Chemistry; Metallurgy | 11 | Active |
| US9745305B2 | Modulators of methyl modifying enzymes, compositions and uses thereof | Human Necessities | 9 | Active |
| US6506786B2 | HIV protease inhibitors based on amino acid derivatives | Chemistry; Metallurgy | 9 | Expired |
| US9522920B2 | Bromodomain inhibitors and uses thereof | Chemistry; Metallurgy | 9 | Active |
| US6656965B2 | HIV protease inhibitors based on amino acid derivatives | Chemistry; Metallurgy | 8 | Expired |
| US6677367B2 | HIV protease inhibitors based on amino acid derivatives | Chemistry; Metallurgy | 8 | Expired |
| US9763922B2 | Therapeutic compounds and uses thereof | Chemistry; Metallurgy | 8 | Active |
| US6608100B1 | HIV protease inhibitors based on amino acid derivatives | Chemistry; Metallurgy | 8 | Expired |
| US6610689B2 | HIV protease inhibitors based on amino acid derivatives | Chemistry; Metallurgy | 8 | Expired |
| US9328117B2 | Bromodomain inhibitors and uses thereof | Human Necessities | 8 | Active |
| US8796261B2 | Bromodomain inhibitors and uses thereof | Chemistry; Metallurgy | 7 | Active |
| US11078201B2 | Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrol[3,4-c]pyridin-1-ones as HPK1 antagonists | Chemistry; Metallurgy | 5 | Active |
| US11028085B2 | Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as hpk1 antagonists | Chemistry; Metallurgy | 5 | Active |
| US11021481B2 | Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as HPK1 antagonists | Chemistry; Metallurgy | 5 | Active |
| US10206931B2 | Therapeutic compounds and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US10526287B2 | LSD1 inhibitors and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US10239861B2 | Therapeutic compounds and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US10689371B2 | Modulators of methyl modifying enzymes, compositions and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US10150767B2 | Therapeutic compounds and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US11548890B1 | HPK1 antagonists and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US10183009B2 | Therapeutic compounds and uses thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US10308614B2 | Therapeutic compounds and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US10316023B2 | Therapeutic compounds and uses thereof | General | 0 | Revoked |
| US11919912B2 | Modulators of methyl modifying enzymes, compositions and uses thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.